NF-κB plays a major role in the maturation of human dendritic cells induced by NiSO4 but not by DNCB

Toxicological Sciences

Volumn 99, Issue 2, 2007, Pages 488-501

  Ade, Nadège ^a,b   Antonios, Diane ^a,b   Kerdine romer, Saadia ^a,b   Boisleve, Fanny ^a,b   Rousset, Françoise ^c   Pallardy, Marc ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c L'Oréal Advanced Research   (France)

Author keywords

Contact hypersensitivity; Dendritic cells; Hapten; NF B

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HAPTEN; HLA DR ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; NICKEL SULFATE; TRANSCRIPTION FACTOR RELA; CD34 ANTIGEN; CD86 PROTEIN, HUMAN; CYTOKINE; I KAPPA B KINASE; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NICKEL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA PROBE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUTATION; PHENOTYPE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; UMBILICAL CORD BLOOD; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD86; CYTOKINES; DENDRITIC CELLS; DINITROCHLOROBENZENE; HLA-DR ANTIGENS; HUMANS; I-KAPPA B KINASE; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; NICKEL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449119208     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm178     Document Type: Article

References (39)

1. Aiba, S., Manome, H., Nakagawa, S., Mollah, Z. U., Mizuashi, M., Ohtani, T., Yoshino, Y., and Tagami, H. (2003). p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 120, 390-399
2. Aiba, S., Manome, H., Yoshino, Y., and Tagami, H. (2000). In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101, 68-75.
3. Aiba, S., Terunuma, A., Manome, H., and Tagami, H. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27, 3031-3038.
4. Arner, E. S., Bjornstedt, M., and Holmgren, A. (1995). 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J. Biol. Chem. 270, 3479-3482.
5. Arrighi, J. F., Rebsamen, M., Rousset, F., Kindler, V., and Hauser, C. (2001). A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNFalpha, and contact sensitizers. J. Immunol. 166, 3837-3845.
6. Attar, R. M., Macdonald-Bravo, H., Raventos-Suarez, C., Durham, S. K., and Bravo, R. (1998). Expression of constitutively active IkappaB beta in T cells of transgenic mice: Persistent NF-kappaB activity is required for T-cell immune responses. Mol. Cell. Biol. 18, 477-487.
7. Berchtold, S., Muhl-Zurbes, P., Maczek, E., Golka, A., Schuler, G., and Steinkasserer, A. (2002). Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology 205, 231-246.
8. Boisleve, F., Kerdine-Romer, S., and Pallardy, M. (2005). Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-alpha. Toxicology 206, 233-244.
9. Boisleve, F., Kerdine-Romer, S., Rougier-Larzat, N., and Pallardy, M. (2004). Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: Role of TNF-alpha and MAPK. J. Invest. Dermatol. 123, 494-502.
10. Brennan, P., and O'Neill, L. A. (1998). Inhibition of nuclear factor kappaB by direct modification in whole cells-Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem. Pharmacol. 55, 965-973.
11. Bour, H., Peyron, E., Gaucherand, M., Garrigue, J. L., Desvignes, C., Kaiserlian, D., Revillard, J. P., and Nicolas, J. F. (1995). Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25, 3006-3010.
12. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., and Banchereau, J. (1996). CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184, 695-706.
13. Cloutier, A., Ear, T., Blais-Charron, E., Dubois, C. M., and McDonald, P. P. Differential involvement of NF-{kappa}B and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils. J. Leukoc. Biol. 81, 567-577.
14. Craig, R., Larkin, A., Mingo, A. M., Thuerauf, D. J., Andrews, C., McDonough, P. M., and Glembotski, C. C. (2000). p38 MAPK and NFkappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J. Biol. Chem. 275, 23814-23824.
15. De Smedt, A. C., Van Den Heuvel, R. L., Van Tendeloo, V. F., Berneman, Z. N., and Schoeters, G. E. (2005). Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants. Toxicol. Lett. 156, 377-389.
16. De Smedt, A. C., Van Den Heuvel, R. L., Zwi Berneman, N., and Schoeters, G. E. (2001). Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. Toxicol. In Vitro 15, 319-325.
17. Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
18. Goebeler, M., Roth, J., Brocker, E. B., Sorg, C., and Schulze-Osthoff, K. (1995). Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J. Immunol. 155, 2459-2467.
19. Handley, M. E., Thakker, M., Pollara, G., Chain, B. M., and Katz, D. R. (2005). JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis. Free Radic. Biol. Med. 38, 1637-1652.
20. Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., and Kracht, M. (2002). Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72, 847-855.
21. Korn, S. H., Wouters, E. F., Vos, N., and Janssen-Heininger, Y. M. (2001). Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J. Biol. Chem. 276, 35693-35700.
22. Kühn, U., Brand, P., Willemsen, J., Jonuleit, H., Enk, A. H., van Brandwijk- Petershans, R., Saloga, J., Knop, J., and Becker, D. (1998). Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J. Immunol. 160, 667-673.
23. Laderach, D., Compagno, D., Danos, O., Vainchenker, W., and Galy, A. (2003). RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J. Immunol. 171, 1750-1757.
24. Li, J., Colovai, A. I., Cortesini, R., and Suciu-Foca, N. (2000). Cloning and functional characterization of the 5#-regulatory region of the human CD86 gene. Hum. Immunol. 61, 486-98.
25. Mizuashi, M., Ohtani, T., Nakagawa, S., and Aiba, S. (2005). Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 124, 579-586.
26. Nordberg, J., Zhong, L., Holmgren, A., and Arner, E. S. (1998). Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 273, 10835-10842.
27. O'Sullivan, B. J., and Thomas, R. (2002). CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB. J. Immunol. 168, 5491-5498.
28. Richter, G., Hayden-Ledbetter, M., Irgang, M., Ledbetter, J. A., Westermann, J., Kor̈ner, I., Daemen, K., Clark, E. A., Aicher, A., and Pezzuto, A. (2001). Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells. J. Biol. Chem. 276, 45686-45693.
29. Rougier, N., Redziniak, G., Mougin, D., Schmitt, D., and Vincent, C. (2000). In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells. Toxicology 145, 73-82.
30. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 1109-1118.
31. Staquet, M. J., Sportouch, M., Jacquet, C., Schmitt, D., Guesnet, J., and Peguet- Navarro, J. (2004). Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. Toxicol. In Vitro 18, 493-500.
32. Toebak, M. J., Pohlmann, P. R., Sampat-Sardjoepersad, S. C., von Blomberg, B. M., Bruynzeel, D. P., Scheper, R. J., Rustemeyer, T., and Gibbs, S. (2005). CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro 20, 117-124.
33. Tuschl, H., and Kovac, R. (2001). Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol. In Vitro 15, 327-331. Tuschl, H., Kovac, R., and Weber, E. (2000). The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14, 541-549.
34. Verhasselt, V., Buelens, C., Willems, F., De Groote, D., Haeffner-Cavaillon, N., and Goldman, M. (1997). Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J. Immunol. 158, 2919-2925.
35. Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems, F., Haegeman, G., and Goldman, M. (1999). N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-kappaB inhibition. J. Immunol. 162, 2569-2574.
36. Verheyen, G. R., Schoeters, E., Nuijten, J. M., Van Den Heuvel, R. L., Nelissen, I., Witters, H., Van Tendeloo, V. F., Berneman, Z. N., and Schoeters, G. E. (2005). Cytokine transcript profiling in CD34+-progenitor derived dendritic cells exposed to contact allergens and irritants. Toxicol. Lett. 155, 187-194.
37. Wery-Zennaro, S., Letourneur, M., David, M., Bertoglio, J., and Pierre, J. (1999). Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation. FEBS Lett. 464, 91-96.
38. Yoshimoto, T., Kojima, K., Funakoshi, T., Endo, Y., Fujita, T., and Nariuchi, H. (1996). Molecular cloning and characterization of murine IL-12 genes. J. Immunol. 156, 1082-1088.
39. Yoshimura, S., Bondeson, J., Foxwell, B. M., Brennan, F. M., and Feldmann, M. (2001). Effective antigen presentation by dendritic cells is NF-kappaB dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 13, 675-683.